1. Home
  2. ZCMD vs GRCE Comparison

ZCMD vs GRCE Comparison

Compare ZCMD & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZCMD
  • GRCE
  • Stock Information
  • Founded
  • ZCMD 2012
  • GRCE 2002
  • Country
  • ZCMD China
  • GRCE United States
  • Employees
  • ZCMD N/A
  • GRCE N/A
  • Industry
  • ZCMD Other Consumer Services
  • GRCE
  • Sector
  • ZCMD Real Estate
  • GRCE
  • Exchange
  • ZCMD Nasdaq
  • GRCE NYSE
  • Market Cap
  • ZCMD 35.3M
  • GRCE 30.9M
  • IPO Year
  • ZCMD 2020
  • GRCE N/A
  • Fundamental
  • Price
  • ZCMD $1.45
  • GRCE $3.36
  • Analyst Decision
  • ZCMD
  • GRCE
  • Analyst Count
  • ZCMD 0
  • GRCE 0
  • Target Price
  • ZCMD N/A
  • GRCE N/A
  • AVG Volume (30 Days)
  • ZCMD 6.1K
  • GRCE 69.2K
  • Earning Date
  • ZCMD 01-01-0001
  • GRCE 02-14-2025
  • Dividend Yield
  • ZCMD N/A
  • GRCE N/A
  • EPS Growth
  • ZCMD N/A
  • GRCE N/A
  • EPS
  • ZCMD N/A
  • GRCE N/A
  • Revenue
  • ZCMD $17,406,104.00
  • GRCE N/A
  • Revenue This Year
  • ZCMD N/A
  • GRCE N/A
  • Revenue Next Year
  • ZCMD N/A
  • GRCE N/A
  • P/E Ratio
  • ZCMD N/A
  • GRCE N/A
  • Revenue Growth
  • ZCMD 1.01
  • GRCE N/A
  • 52 Week Low
  • ZCMD $1.00
  • GRCE $2.13
  • 52 Week High
  • ZCMD $5.10
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • ZCMD 44.73
  • GRCE N/A
  • Support Level
  • ZCMD $1.34
  • GRCE N/A
  • Resistance Level
  • ZCMD $1.51
  • GRCE N/A
  • Average True Range (ATR)
  • ZCMD 0.11
  • GRCE 0.00
  • MACD
  • ZCMD 0.01
  • GRCE 0.00
  • Stochastic Oscillator
  • ZCMD 39.66
  • GRCE 0.00

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: